AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $858,000 | -91.7% | 341,779 | -55.2% | 0.28% | -90.7% |
Q2 2020 | $10,357,000 | +60.1% | 762,666 | -10.6% | 2.99% | +10.7% |
Q1 2020 | $6,470,000 | +32.9% | 853,538 | +10.8% | 2.70% | +61.5% |
Q4 2019 | $4,870,000 | +50.0% | 770,538 | -6.9% | 1.67% | +36.9% |
Q3 2019 | $3,246,000 | -19.3% | 828,038 | -0.3% | 1.22% | -19.2% |
Q2 2019 | $4,020,000 | -31.4% | 830,538 | +16.1% | 1.51% | -40.2% |
Q1 2019 | $5,860,000 | +48.1% | 715,538 | 0.0% | 2.53% | +28.5% |
Q4 2018 | $3,957,000 | -28.4% | 715,538 | +14.4% | 1.97% | -13.3% |
Q3 2018 | $5,525,000 | -9.4% | 625,738 | +2.5% | 2.27% | -20.5% |
Q2 2018 | $6,095,000 | +4.7% | 610,738 | 0.0% | 2.85% | +0.8% |
Q1 2018 | $5,820,000 | +188.4% | 610,738 | +349.9% | 2.83% | +160.4% |
Q4 2017 | $2,018,000 | -24.4% | 135,738 | 0.0% | 1.09% | -34.4% |
Q3 2017 | $2,670,000 | +36.9% | 135,738 | 0.0% | 1.66% | +19.1% |
Q2 2017 | $1,951,000 | +201.1% | 135,738 | +92.7% | 1.39% | +154.0% |
Q1 2017 | $648,000 | +250.3% | 70,455 | +185.2% | 0.55% | +272.8% |
Q2 2016 | $185,000 | -68.8% | 24,700 | -62.4% | 0.15% | -71.2% |
Q1 2016 | $592,000 | – | 65,700 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |